Skip to main content
Frontiers in Pharmacology logoLink to Frontiers in Pharmacology
. 2024 Mar 13;15:1382529. doi: 10.3389/fphar.2024.1382529

Corrigendum: Unveiling the therapeutic potential of exogenous β-hydroxybutyrate for chronic colitis in rats: novel insights on autophagy, apoptosis, and pyroptosis

Rasha Abdelhady 1, Sameh Saber 2,*, Mustafa Ahmed Abdel-Reheim 3,4,*, Mohannad Mohammad S Alamri 5, Jaber Alfaifi 6, Masoud I E Adam 7, Lobna A Saleh 8,9, Azza I Farag 10, Elsayed A Elmorsy 11,12, Hend S El-Wakeel 13,14, Ahmed S Doghish 15,16, Mohamed E Shaker 17, Sara H Hazem 18, Heba A Ramadan 19, Rabab S Hamad 20,21, Osama A Mohammed 8,22,*
PMCID: PMC10966404  PMID: 38545556

In the published article, there was an error in affiliations 11 and 12. Instead of:

“11Department of Clinical Pharmacology, Faculty of Medicine, Mansoura University, Mansoura, Egypt.”

“12Pharmacology and Therapeutics Department, Qassim College of Medicine, Qassim University, Buraydah, Saudi Arabia.”

it should be:

“11Department of Pharmacology and Therapeutics, Qassim College of Medicine, Qassim University, Buraydah, Saudi Arabia.”

“12Department of Clinical Pharmacology, Faculty of Medicine, Mansoura University, Mansoura, Egypt.”

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.


Articles from Frontiers in Pharmacology are provided here courtesy of Frontiers Media SA

RESOURCES